FB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Reduced sclerostin expression in human atherosclerotic plaques links to ischemic stroke | Journal of the American Heart Association. Cardiovascular and cerebrovascular disease | 2024 | 10 | 1 | |||
Circulating GDF11 exacerbates myocardial injury in mice and associates with increased infarct size in humans | Cardiovascular research | 2023 | 27 | 15 | |||
Epitope of antiphospholipid antibodies retrieved from peptide microarray based on R39-R43 of β2-glycoprotein I | Research and practice in thrombosis and haemostasis | 2022 | 143 | 131 | |||
High antibody titers against apolipoprotein-A1 in NAFLD: a possible link between fatty liver disease and CVD? | 90th European Atherosclerosis Society (EAS) congress | 2022 | 125 | 0 | |||
Single-cell analysis uncovers osteoblast factor growth differentiation factor 10 as mediator of vascular smooth muscle cell phenotypic modulation associated with plaque rupture in human carotid artery disease | International journal of molecular sciences | 2022 | 153 | 175 | |||
Single-Cell RNA-Seq Reveals a Crosstalk between Hyaluronan Receptor LYVE-1-Expressing Macrophages and Vascular Smooth Muscle Cells | Cells | 2022 | 168 | 165 | |||
NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis | International journal of molecular sciences | 2021 | 184 | 136 | |||
Autoantibodies directed against apolipoprotein-A1 as a potential contributor to Non-Alcoholic Fatty Liver Disease | 89th Europen Society of Atherosclerosis (EAS) | 2021 | 70 | 0 | |||
Follicular regulatory helper T cells control the response of regulatory B cells to a high-cholesterol diet | Cardiovascular Research | 2021 | 165 | 80 | |||
Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques | International Journal of Molecular Sciences | 2020 | 204 | 95 | |||
Cardiotrophin-1 Deficiency Abrogates Atherosclerosis Progression | Scientific Reports | 2020 | 180 | 157 | |||
Atherosclerotic plaque vulnerability is increased in mouse model of lupus | Scientific Reports | 2020 | 284 | 180 | |||
Cardiomyocyte-Specific JunD Overexpression Increases Infarct Size following Ischemia/Reperfusion Cardiac Injury by Downregulating Sirt3 | Thrombosis and Haemostasis | 2020 | 203 | 0 | |||
Prognostic and therapeutic considerations of antibodies against c‐ter apolipoprotein A‐1 in the general population | Clinical & translational immunology | 2020 | 157 | 92 | |||
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence | Journal of cardiovascular medicine | 2020 | 153 | 0 | |||
Vitamin D receptor is expressed within human carotid plaques and correlates with pro-inflammatory M1 macrophages | Vascular pharmacology | 2016 | 511 | 0 | |||
Treatment with anti-RANKL antibody reduces infarct size and attenuates dysfunction impacting on neutrophil-mediated injury | Journal of Molecular and Cellular Cardiology | 2016 | 548 | 1 | |||
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis | Thrombosis and haemostasis | 2016 | 687 | 1 | |||
Anti-ApoA-1 IgG serum levels predict worse post-stroke outcomes | European journal of clinical investigation | 2016 | 580 | 6 | |||
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis | Thrombosis and haemostasis | 2016 | 696 | 538 | |||
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis | Mediators of Inflammation | 2016 | 447 | 175 | |||
Leptin/adiponectin ratio predicts post-stroke neurological outcome | European journal of clinical investigation | 2015 | 533 | 1 | |||
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | European journal of clinical investigation | 2015 | 586 | 0 | |||
Genetic deletion of the adaptor protein p66Shc increases susceptibility to short-term ischaemic myocardial injury via intracellular salvage pathways | European heart journal | 2015 | 613 | 2 | |||
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response | Vascular pharmacology | 2015 | 686 | 0 | |||
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways | Vascular pharmacology | 2015 | 791 | 4 | |||
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways | Thrombosis and haemostasis | 2015 | 736 | 0 | |||
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic mice | Vascular pharmacology | 2015 | 565 | 0 | |||
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 | Thrombosis and haemostasis | 2015 | 587 | 5 | |||
Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis | European journal of clinical investigation | 2014 | 615 | 0 | |||
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice | Thrombosis and haemostasis | 2014 | 743 | 0 | |||
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in mice | Thrombosis and haemostasis | 2013 | 694 | 0 | |||
Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice | Journal of cerebral blood flow and metabolism | 2013 | 675 | 0 | |||
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury | Journal of Molecular and Cellular Cardiology | 2013 | 599 | 0 | |||
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice | Arteriosclerosis, thrombosis, and vascular biology | 2013 | 459 | 1 | |||
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques | European heart journal | 2012 | 668 | 0 | |||
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice | Journal of Molecular and Cellular Cardiology | 2010 | 679 | 0 | |||
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion | Journal of Molecular and Cellular Cardiology | 2009 | 728 | 0 | |||
HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial | AIDS | 2009 | 620 | 0 | |||
Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes | Rheumatology | 2009 | 610 | 0 | |||
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis | Atherosclerosis | 2009 | 569 | 0 | |||
Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways | Cellular signalling | 2008 | 658 | 0 | |||
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes | Journal of leukocyte biology | 2008 | 598 | 0 | |||
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways | American journal of physiology. Heart and circulatory physiology | 2008 | 587 | 0 | |||
A novel RANTES antagonist prevents progression of established atherosclerotic lesions in mice | Arteriosclerosis, thrombosis, and vascular biology | 2008 | 633 | 0 | |||
Atorvastatin treatment and vaccination efficacy | Journal of clinical pharmacology | 2007 | 574 | 0 |